Long Grove Pharmaceuticals is expanding its product offerings through an in-licensing of cyclophosphamide for injection, USP from Sunny Pharmtech. Cyclophosphamide for injection, USP, is an antineoplastic chemotherapy medication that slows the growth of cancer cells. It is used to treat multiple malignant diseases, including blood cancers and solid tumors. Sunny Pharmtech received FDA approval for the drug through an Abbreviated New Drug Application (ANDA) in October 2023. It is currently available in 500 mg, 1 g, and 2 g dry powder vials.